The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics

被引:2
作者
Dimeglio, Chloe [1 ,2 ]
Loubes, Jean-Michel [3 ]
Miedouge, Marcel [2 ]
Herin, Fabrice [4 ]
Soulat, Jean-Marc [4 ]
Izopet, Jacques [1 ,2 ]
机构
[1] Toulouse Inst Infect & Inflammatory Dis INFINITy, 2 INSERM UMR1291, CNRS UMR5051, F-31300 Toulouse, France
[2] CHU Toulouse, Hop Purpan, Virol Lab, F-31300 Toulouse, France
[3] Univ Toulouse, Inst Math Toulouse, F-31400 Toulouse, France
[4] Toulouse Purpan Univ Hosp, Occupat Dis Dept, F-31000 Toulouse, France
关键词
D O I
10.1038/s41598-021-92131-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The SARS-CoV-2 virus has spread world-wide since December 2019, killing more than 2.9 million of people. We have adapted a statistical model from the SIR epidemiological models to predict the spread of SARS-CoV-2 in France. Our model is based on several parameters and assumed a 4.2% seroprevalence in Occitania after the first lockdown. The recent use of serological tests to measure the effective seroprevalence of SARS-CoV-2 in the population of Occitania has led to a seroprevalence around 2.4%. This implies to review the parameters of our model to conclude at a lower than expected virus transmission rate, which may be due to infectivity varying with the patient's symptoms or to a constraint due to an uneven population geographical distribution.
引用
收藏
页数:5
相关论文
共 31 条
[1]   Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein [J].
Abravanel, Florence ;
Miedouge, Marcel ;
Chapuy-Regaud, Sabine ;
Mansuy, Jean-Michel ;
Izopet, Jacques .
JOURNAL OF CLINICAL VIROLOGY, 2020, 130
[2]  
[Anonymous], R: A language and environment for statistical computing
[3]   Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort [J].
Carrat, Fabrice ;
Figoni, Julie ;
Henny, Joseph ;
Desenclos, Jean-Claude ;
Kab, Sofiane ;
de Lamballerie, Xavier ;
Zins, Marie .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2021, 36 (02) :219-222
[4]   Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection [J].
Chang, De ;
Mo, Guoxin ;
Yuan, Xin ;
Tao, Yi ;
Peng, Xiaohua ;
Wang, Fu-Sheng ;
Xie, Lixin ;
Sharma, Lokesh ;
Dela Cruz, Charles S. ;
Qin, Enqiang .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (09) :1150-1152
[5]  
Dattner I, 2020, The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children
[6]   Quantifying the impact of public health protection measures on the spread of SARS-CoV-2 [J].
Dimeglio, Chloe ;
Loubes, Jean-Michel ;
Mansuy, Jean-Michel ;
Izopet, Jacques .
JOURNAL OF INFECTION, 2021, 82 (03) :414-415
[7]   Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France [J].
Dimeglio, Chloe ;
Miedouge, Marcel ;
Loubes, Jean-Michel ;
Mansuy, Jean-Michel ;
Izopet, Jacques .
REVIEWS IN MEDICAL VIROLOGY, 2021, 31 (05) :1-8
[8]   Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France [J].
Dimeglio, Chloe ;
Herin, Fabrice ;
Miedouge, Marcel ;
Cambus, Jean-Pierre ;
Abravanel, Florence ;
Mansuy, Jean-Michel ;
Soulat, Jean-Marc ;
Izopet, Jacques .
JOURNAL OF INFECTION, 2021, 82 (01) :E29-E32
[9]   Children are protected against SARS-CoV-2 infection [J].
Dimeglio, Chloe ;
Mansuy, Jean-Michel ;
Charpentier, Sandrine ;
Claudet, Isabelle ;
Izopet, Jacques .
JOURNAL OF CLINICAL VIROLOGY, 2020, 128
[10]   The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France [J].
Dimeglio, Chloe ;
Loubes, Jean-Michel ;
Deporte, Benjamin ;
Dubois, Martine ;
Latour, Justine ;
Mansuy, Jean-Michel ;
Izopet, Jacques .
JOURNAL OF INFECTION, 2020, 81 (02) :348-351